Effect of 3 Weeks Treatment with Yohimbine on Salivary Secretion in Healthy Volunteers and in Depressed Patients Treated with Tricyclic Antidepressants
Overview
Authors
Affiliations
The effect of yohimbine treatment (4 mg three times daily) for 3 weeks on salivary secretion was investigated. In healthy volunteers, acute administration of yohimbine increased salivary volume within 1 h to a similar extent before and at the end of the treatment period. In depressed patients treated with tricyclic antidepressants (and exhibiting a reduced salivary flow), yohimbine also acutely increased salivary volume. In contrast, the alpha 2-adrenoceptor antagonist failed to modify resting values measured in the morning (i.e. 10 and 14 h after the last administration in healthy volunteers and depressed patients respectively). This result indicates that alpha 2-adrenoceptor antagonists may have a potential therapeutic use in the treatment of dry mouth caused by tricyclic antidepressant drugs.
Iacovelli N, Ingargiola R, Facchinetti N, Franceschini M, Romanello D, Bossi P Cancers (Basel). 2021; 13(14).
PMID: 34298670 PMC: 8303446. DOI: 10.3390/cancers13143456.
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.
Miranda-Rius J, Brunet-Llobet L, Lahor-Soler E, Farre M Int J Med Sci. 2015; 12(10):811-24.
PMID: 26516310 PMC: 4615242. DOI: 10.7150/ijms.12912.
Bagheri H, Picault P, Schmitt L, Houin G, Berlan M, Montastruc J Br J Clin Pharmacol. 1994; 37(1):93-6.
PMID: 8148228 PMC: 1364719. DOI: 10.1111/j.1365-2125.1994.tb04248.x.